These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25203256)

  • 21. Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.
    LeprĂȘtre A; Ba I; Lacombe K; Maynart M; Toufik A; Ndiaye O; Kane CT; Gozlan J; Tine J; Ndoye I; Raguin G; Girard PM
    J Int AIDS Soc; 2015; 18(1):19888. PubMed ID: 26004637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
    Vassilev ZP; Hagan H; Lyubenova A; Tomov N; Vasilev G; Krasteva D; Des Jarlais DC
    Int J STD AIDS; 2006 Sep; 17(9):621-6. PubMed ID: 16942654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
    Liu Y; Liu Y; Zou X; Chen W; Ling L
    BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.
    Rhodes T; Platt L; Maximova S; Koshkina E; Latishevskaya N; Hickman M; Renton A; Bobrova N; McDonald T; Parry JV
    Addiction; 2006 Feb; 101(2):252-66. PubMed ID: 16445554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
    Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
    Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
    Akiyama MJ; Cleland CM; Lizcano JA; Cherutich P; Kurth AE
    Lancet Infect Dis; 2019 Nov; 19(11):1255-1263. PubMed ID: 31540840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.
    Solomon SS; Srikrishnan AK; Mehta SH; Vasudevan CK; Murugavel KG; Thamburaj E; Anand S; Kumar MS; Latkin C; Solomon S; Celentano DD
    J Acquir Immune Defic Syndr; 2008 Nov; 49(3):327-32. PubMed ID: 18845962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
    Tan Y; Wei QH; Chen LJ; Chan PC; Lai WS; He ML; Kung HF; Lee SS
    PLoS One; 2008; 3(10):e3608. PubMed ID: 18974888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.
    Xia X; Luo J; Bai J; Yu R
    Public Health; 2008 Oct; 122(10):990-1003. PubMed ID: 18486955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infection status and risk factors of HIV, HBV, HCV, and syphilis among drug users in Guangdong, China--a cross-sectional study.
    Wu J; Huang J; Xu D; Lu C; Deng X; Zhou X
    BMC Public Health; 2010 Nov; 10():657. PubMed ID: 21040549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: recruitment dynamics and impact on estimates of HIV and syphilis prevalence.
    Frost SD; Brouwer KC; Firestone Cruz MA; Ramos R; Ramos ME; Lozada RM; Magis-Rodriguez C; Strathdee SA
    J Urban Health; 2006 Nov; 83(6 Suppl):i83-97. PubMed ID: 17072761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Injecting drug use and HIV infection in southwest China.
    Zheng X; Tian C; Choi KH; Zhang J; Cheng H; Yang X; Li D; Lin J; Qu S; Sun X
    AIDS; 1994 Aug; 8(8):1141-7. PubMed ID: 7986413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV prevalence and risk behavior among injection drug users and their sex partners in two Russian cities.
    Eritsyan KU; Levina OS; White E; Smolskaya TT; Heimer R
    AIDS Res Hum Retroviruses; 2013 Apr; 29(4):687-90. PubMed ID: 23186172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan province, China.
    Zhou YH; Yao ZH; Liu FL; Li H; Jiang L; Zhu JW; Zheng YT
    PLoS One; 2012; 7(8):e42937. PubMed ID: 22916185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
    Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
    Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Survey of prevalence of HIV infection, syphilis and HCV infection and related risk behaviors among club drug users in Zhejiang, 2011].
    Pan X; Jiang J; He H; Chen L; Yang J; Zhang H; Wang N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Sep; 36(9):934-40. PubMed ID: 26814857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sharing of needles and paraphernalia injection in new and long-term injection drug users in Sichuan, China].
    Liu JB; Zhang LL; Lai WH; Feng L; Zeng YL; Liu L; Hu Y; Li J; Zhang XL; Xiao Y; Vermund SH; Jia YJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jul; 30(7):656-62. PubMed ID: 19957584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.